State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, PR China; Key Laboratory of Biotechnology and Bioresources Utilization of Ministry of Education, Dalian Minzu University, Dalian 116600, PR China.
College of Pharmacy, Dalian Medical University, Dalian 116044, PR China.
Biomater Adv. 2022 Aug;139:212984. doi: 10.1016/j.bioadv.2022.212984. Epub 2022 Jun 14.
Ionizable cationic lipids have great potential for gene delivery, yet the effect of the molecular structure of such lipids on gene delivery efficiency is an ongoing research challenge. To better understand corresponding structure-function activity relationships, we synthesized four ester-linked, pH-responsive, ionizable cationic lipids. The screened DEDM4 lipid, containing 2-ethylenedimethylamine in the headgroup and a branched-chain tail, exhibited a high delivery efficacy of plasmid DNA and siRNA in A549 cells, which was comparable with that of the commercial reagent lipofectamine 3000 (lipo3000). Moreover, because of its pK value of 6.35 and pH-sensitivity under acidic conditions, DEDM4 could carry sufficient positive charge in the acidic environment of endosomes and interact with the endosome lumen, leading to destruction of the endomembrane and subsequent release of siRNA into the cytoplasm with endosomal escape. Furthermore, we used DEDM4 to deliver IGF-1R siRNA to induce cancer cell apoptosis, thereby leading to great tumor inhibition. More importantly, it also showed very low toxicity in vivo. These structure-activity data for DEDM4 demonstrate potential clinical applications of DEDM4-mediated gene delivery for cancer.
可离子化的阳离子脂质体在基因传递方面具有巨大的潜力,但此类脂质的分子结构对基因传递效率的影响仍然是一个持续的研究挑战。为了更好地理解相应的结构-功能活性关系,我们合成了四种酯键连接的、pH 响应的、可离子化的阳离子脂质体。经过筛选,含有 2-乙烯二甲基胺头基和支链尾部的 DEDM4 脂质在 A549 细胞中表现出了高的质粒 DNA 和 siRNA 的传递效率,与商业试剂 lipofectamine 3000(lipo3000)相当。此外,由于其 pK 值为 6.35,在酸性条件下具有 pH 敏感性,DEDM4 可以在内涵体的酸性环境中携带足够的正电荷,并与内涵体腔相互作用,导致内涵体膜的破坏,随后 siRNA 进入细胞质,内涵体逃逸。此外,我们使用 DEDM4 传递 IGF-1R siRNA 来诱导癌细胞凋亡,从而导致肿瘤的显著抑制。更重要的是,它在体内的毒性也非常低。DEDM4 的这些结构-活性数据表明,DEDM4 介导的基因传递在癌症治疗方面具有潜在的临床应用价值。